<DOC>
	<DOCNO>NCT01584791</DOCNO>
	<brief_summary>The aim current study compare antiplatelet efficacy safety clopidogrel napadisilate clopidogrel bisulfate Coronary Artery Disease ( CAD ) patient coronary stent implantation .</brief_summary>
	<brief_title>Korean Multicenter Randomized Controlled Trial ( RCT ) Pidogul Patients With Coronary Stenting</brief_title>
	<detailed_description />
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Aspirin</mesh_term>
	<mesh_term>Ticlopidine</mesh_term>
	<mesh_term>Clopidogrel</mesh_term>
	<criteria>Korean men woman age 20 85 Patients diagnosed CAD Patients plan undergo PCI Patients treat PCI intend treat PCI fail Patients take take antiplatelet anticoagulant 2 week within prior 30 day Patients history alcohol abuse intoxication ; ( 4 ) hypersensitivity clopidogrel aspirin Patients hypersensitivity clopidogrel aspirin Patients abnormal laboratory result indicative liver disease Patients blood coagulation disorder , uncontrolled severe hypertension , active bleeding , history severe bleeding , intracranial hemorrhage ulcer bleed Patients pregnant , breastfeeding , use effective method contraception Patients contraindication study drug Patients participate another clinical study within 4 week prior start study</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>April 2012</verification_date>
	<keyword>CAD</keyword>
	<keyword>PCI</keyword>
	<keyword>Percutaneous Coronary Intervention</keyword>
</DOC>